Innovus Pharma Reports Another New Quarterly Revenue Record of Approximately $7.4 Million for the Third Quarter 2018 and $19.2 Million for the First Nine Months of 2018

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. GOOGL
6. RTX
7. COF
8. SMCI
9. TSLA
10. BRZE

Go back to Innovus Pharma Reports Another New Quarterly Revenue Record of Approximately $7.4 Million for the Third Quarter 2018 and $19.2 Million for the First Nine Months of 2018

Innovus Pharma (INNV) Reports Q3 Loss of $0.01

November 14, 2018 4:27 PM EST

Innovus Pharma (OTC: INNV) reported Q3 EPS of ($0.01), versus ($0.01) reported last year. Revenue for the quarter came in at $7.4 million, versus $2.22 million reported last year.

Revenues of approximately $7.4 million, highest gross revenue quarter in Companys history and up 232% year-over-year;Gross margin remains relatively consistent at 79% from prior quarter;Quarter subscription net revenue increased 31.7% from prior quarter to $861,000;Sales & Marketing expenses declined 4.3% from prior quarter to 71.3%Fifth straight quarter... More